87 research outputs found
The hot-hand fallacy in cognitive control: Repetition expectancy modulates the congruency sequence effect
Recommended from our members
Contractility defects hinder glycoprotein VI-mediated platelet activation and affect platelet functions beyond clot contraction
ABSTRACT
Background: Active and passive biomechanical properties of platelets contribute substantially to thrombus formation. Actomyosin contractility drives clot contraction required for stabilizing the hemostatic plug. Impaired contractility results in bleeding but is difficult to detect using
platelet function tests.
Objectives: To determine how diminished myosin activity affects platelet functions including and beyond clot contraction.
Methods: Using the myosin IIA-specific pharmacological inhibitor blebbistatin, we tuned myosin activity in platelets from healthy donors and systematically characterized platelet responses at various levels of inhibition using a range of complementary assays interrogating distinct platelet functions at each stage of thrombus formation.
Results: Partial myosin IIA inhibition did not affect platelet von Willebrand Factor interactions
under arterial shear nor spreading and cytoskeletal rearrangements on fibrinogen. However, it impacted stress fiber formation and the nanoarchitecture of cell-matrix adhesions, drastically reducing and limiting traction forces. Higher blebbistatin concentrations impaired platelet adhesion under flow, altered mechanosensing at lamellipodia edges, and eliminated traction forces without affecting spreading, α-granule secretion, or procoagulant platelet
formation. Unexpectedly, myosin IIA inhibition reduced calcium influx, dense granule secretion and platelet aggregation downstream of glycoprotein (GP) VI and limited the redistribution of GPVI on the cell membrane, whereas aggregation induced by ADP or arachidonic acid were unaffected.
Conclusions: Our findings highlight the importance of both active contractile and passive crosslinking roles of myosin IIA in the platelet cytoskeleton. They support the hypothesis that highly contractile platelets are needed for hemostasis and further suggest a supportive role for myosin IIA in GPVI signaling
Population pharmacokinetics of colistin and the relation to survival in critically ill patients infected with colistin susceptible and carbapenem-resistant bacteria
Objectives: The aim was to analyse the population pharmacokinetics of colistin and to explore the relationship between colistin exposure and time to death. Methods: Patients included in the AIDA randomized controlled trial were treated with colistin for severe infections caused by carbapenem-resistant Gram-negative bacteria. All subjects received a 9 million units (MU) loading dose, followed by a 4.5 MU twice daily maintenance dose, with dose reduction if creatinine clearance (CrCL) 2 mg/L in 94% (195/208) and 44% (38/87) of patients with CrCL ≤120 mL/min, and >120 mL/min, respectively. Colistin methanesulfonate sodium (CMS) and colistin clearances were strongly dependent on CrCL. High colistin exposure to MIC ratio was associated with increased hazard of death in the multivariate analysis (adjusted hazard ratio (95% CI): 1.07 (1.03–1.12)). Other significant predictors included SOFA score at baseline (HR 1.24 (1.19–1.30) per score increase), age and Acinetobacter or Pseudomonas as index pathogen. Discussion: The population pharmacokinetic model predicted that >90% of the patients had colistin concentrations
Vancomycin exposure and acute kidney injury outcome: A Snapshot From the CAMERA2 Study
Among patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteremia from a prospective randomized clinical trial, acute kidney injury (AKI) rates increased with increasing vancomycin exposure, even within the therapeutic range. AKI was independently more common for the (flu)cloxacillin group. Day 2 vancomycin AUC ≥470 mg·h/L was significantly associated with AKI, independent of (flu)cloxacillin receipt
Exploiting genomics for antimicrobial resistance surveillance at One Health interfaces.
The intersection of human, animal, and ecosystem health at One Health interfaces is recognised as being of key importance in the evolution and spread of antimicrobial resistance (AMR) and represents an important, and yet rarely realised opportunity to undertake vital AMR surveillance. A working group of international experts in pathogen genomics, AMR, and One Health convened to take part in a workshop series and online consultation focused on the opportunities and challenges facing genomic AMR surveillance in a range of settings. Here we outline the working group's discussion of the potential utility, advantages of, and barriers to, the implementation of genomic AMR surveillance at One Health interfaces and propose a series of recommendations for addressing these challenges. Embedding AMR surveillance at One Health interfaces will require the development of clear beneficial use cases, especially in low-income and middle-income countries. Evidence of directionality, risks to human and animal health, and potential trade implications were also identified by the working group as key issues. Addressing these challenges will be vital to enable genomic surveillance technology to reach its full potential for assessing the risk of transmission of AMR between the environment, animals, and humans at One Health interfaces.
An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers
Introduction: Individuals carrying pathogenic mutations in the BRCA1 and BRCA2 genes have a high lifetime risk of breast cancer. BRCA1 and BRCA2 are involved in DNA double-strand break repair, DNA alterations that can be caused by exposure to reactive oxygen species, a main source of which are mitochondria. Mitochondrial genome variations affect electron transport chain efficiency and reactive oxygen species production. Individuals with different mitochondrial haplogroups differ in their metabolism and sensitivity to oxidative stress. Variability in mitochondrial genetic background can alter reactive oxygen species production, leading to cancer risk. In the present study, we tested the hypothesis that mitochondrial haplogroups modify breast cancer risk in BRCA1/2 mutation carriers. Methods: We genotyped 22,214 (11,421 affected, 10,793 unaffected) mutation carriers belonging to the Consortium of Investigators of Modifiers of BRCA1/2 for 129 mitochondrial polymorphisms using the iCOGS array. Haplogroup inference and association detection were performed using a phylogenetic approach. ALTree was applied to explore the reference mitochondrial evolutionary tree and detect subclades enriched in affected or unaffected individuals. Results: We discovered that subclade T1a1 was depleted in affected BRCA2 mutation carriers compared with the rest of clade T (hazard ratio (HR) = 0.55; 95% confidence interval (CI), 0.34 to 0.88; P = 0.01). Compared with the most frequent haplogroup in the general population (that is, H and T clades), the T1a1 haplogroup has a HR of 0.62 (95% CI, 0.40 to 0.95; P = 0.03). We also identified three potential susceptibility loci, including G13708A/rs28359178, which has demonstrated an inverse association with familial breast cancer risk. Conclusions: This study illustrates how original approaches such as the phylogeny-based method we used can empower classical molecular epidemiological studies aimed at identifying association or risk modification effects.Peer reviewe
A novel paleo-bleaching proxy using boron isotopes and high-resolution laser ablation to reconstruct coral bleaching events
Coral reefs occupy only ~ 0.1 percent of the ocean's habitat, but are the most biologically diverse marine ecosystem. In recent decades, coral reefs have experienced a significant global decline due to a variety of causes, one of the major causes being widespread coral bleaching events. During bleaching, the coral expels its symbiotic algae, thereby losing its main source of nutrition generally obtained through photosynthesis. While recent coral bleaching events have been extensively investigated, there is no scientific data on historical coral bleaching prior to 1979. In this study, we employ high-resolution femtosecond Laser Ablation Multiple Collector Inductively Coupled Plasma Mass Spectrometry (LA-MC-ICP-MS) to demonstrate a distinct biologically induced decline of boron (B) isotopic composition (δ11B) as a result of coral bleaching. These findings and methodology offer a new use for a previously developed isotopic proxy to reconstruct paleo-coral bleaching events. Based on a literature review of published δ11B data and our recorded vital effect of coral bleaching on the δ11B signal, we also describe at least two possible coral bleaching events since the Last Glacial Maximum. The implementation of this bleaching proxy holds the potential of identifying occurrences of coral bleaching throughout the geological record. A deeper temporal view of coral bleaching will enable scientists to determine if it occurred in the past during times of environmental change and what outcome it may have had on coral population structure. Understanding the frequency of bleaching events is also critical for determining the relationship between natural and anthropogenic causes of these events
Underwater light field patterns in subtropical coastal waters: A case study from the Gulf of Eilat (Aqaba)
- …